do Couto Fernando Brasil, Yonamine Eduardo Sadao, Magno Felipe Guimarães, Favacho-Silva Ana Beatriz, de Brito Carlos Rafael Alves, Brito Thiago Raphael Brasil
Hospital Ophir Loyola, Orthopaedic Oncology Department, Belém, PA, Brazil.
Santa Casa de Misericórdia de São Paulo, Orthopaedic Oncology Department, São Paulo, SP, Brazil.
Acta Ortop Bras. 2025 Feb 3;33(1):e285342. doi: 10.1590/1413-785220253301e285342. eCollection 2025.
This study aimed to evaluate the profile of patients diagnosed with giant cell tumors treated at the Ophir Loyola Hospital.
An analytical study in the form of a retrospective cohort, conducted through a review of patient medical records and imaging exams of individuals treated at the hospital between January 1, 2020, and December 31, 2021.
A total of 19 patients were evaluated, with an average time of 10.5 months between diagnostic suspicion and the first consultation with the Orthopedic Oncology team.
Among the patients studied, 73% were presented with advanced-stage disease, requiring aggressive surgical treatment with wide resection and replacement with an endoprosthesis.
本研究旨在评估在奥菲尔·洛约拉医院接受治疗的巨细胞瘤患者的概况。
采用回顾性队列分析研究,通过查阅2020年1月1日至2021年12月31日期间在该医院接受治疗的患者的病历和影像学检查进行。
共评估了19例患者,从诊断怀疑到首次咨询骨肿瘤学团队的平均时间为10.5个月。
在所研究的患者中,73%患有晚期疾病,需要进行广泛切除并使用假体置换的积极手术治疗。